Regression of hypertrophy in remote myocardium after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: A magnetic resonance imaging follow-up study

被引：0
|
作者：
van Dockum, WG
Gotte, MJW
Beek, AM
ten Cate, FJ
ten Berg, JM
Hofman, MBM
Visser, CA
van Rossum, AC
机构：
[1] VU Univ, Med Ctr, Amsterdam, Netherlands
[2] Erasmus Med Ctr, Rotterdam, Netherlands
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2004年 / 43卷 / 05期
关键词：
D O I：
10.1016/S0735-1097(04)90704-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：166A / 166A
页数：1
相关论文
共 50 条
  • [21] MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    Amano, Yasuo
    Takayama, Morimasa
    Kumita, Shinichiro
    Kumazaki, Tatsuo
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2007, 31 (04) : 600 - 604
  • [22] Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    Butz, T.
    Horstkotte, D.
    Koerfer, J.
    Langer, C.
    Seggewiss, H.
    Faber, L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 145 (01) : E3 - E5
  • [23] Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Seggewiss, H.
    Rigopoulos, A.
    Welge, D.
    Ziemssen, P.
    Faber, L.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (12) : 856 - 863
  • [24] Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy
    Hubert Seggewiss
    Angelos Rigopoulos
    Dirk Welge
    Peer Ziemssen
    Lothar Faber
    Clinical Research in Cardiology, 2007, 96 : 856 - 863
  • [25] Mid-term follow up results after percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM)
    Seggewiss, H
    Faber, L
    Gleichmann, U
    Fassbender, D
    Strick, S
    Schmidt, HK
    Ziemssen, P
    CIRCULATION, 1997, 96 (08) : 2586 - 2586
  • [26] Percutaneous transluminal septal myocardial ablation: A new treatment for hypertrophic obstructive cardiomyopathy
    Seggewiss, H
    EUROPEAN HEART JOURNAL, 2000, 21 (09) : 704 - 707
  • [27] Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients
    Seggewiss, H
    Gleichmann, U
    Faber, L
    Fassbender, D
    Schmidt, HK
    Strick, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 252 - 258
  • [28] Midterm follow-up after transluminal alcohol septal ablation of hypertrophic obstructive cardiomyopathy: A real-world study
    Chawla, K.
    Lefevre, T.
    Morice, M. C.
    Khand, A.
    Laurent, I.
    Malergue, M. C.
    Cormier, B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 43C - 43C
  • [29] Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
    Qin, JX
    Shiota, T
    Lever, HM
    Kapadia, SR
    Sitges, M
    Rubin, DN
    Bauer, F
    Greenberg, NL
    Agler, DA
    Drinko, JK
    Martin, M
    Tuzcu, EM
    Smedira, NG
    Lytle, B
    Thomas, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) : 1994 - 2000
  • [30] Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients
    Faber, L
    Meissner, A
    Ziemssen, P
    Seggewiss, H
    HEART, 2000, 83 (03) : 326 - 331
12345